The future leaves
signals in time.

A new nanoparticle therapy reduced lung tumors in mice while also targeting cachexia, the severe muscle wasting that can accompany cancer. By delivering follistatin mRNA directly to tumors, the approach could eventually offer a way to fight both the disease and one of its most dangerous complications, though the evidence so far comes from mouse studies.

Scientists have discovered a human gene called BC200 that appears to play an important role in brain cells while retaining the ability to jump around the genome. Evolved from a transposon millions of years ago, it never lost its mobility, and researchers found it embedded in a human poxvirus, suggesting it may have jumped from infected skin cells into the virus.

Scientists at Memorial Sloan Kettering Cancer Center identified a signaling molecule called MEK that pushes tumor-fighting T cells to burn through their energy while producing cancer-killing proteins. In animal and laboratory studies, blocking MEK helped the cells conserve energy, survive longer, and remain active in the harsh environment around tumors.

According to STAT+, a melanoma vaccine succeeded in a late-stage clinical trial. With divergent results across the cancer vaccine field, the question now is whether other cancer vaccines will work — and whether mRNA is up to the task.

A look at particle physicist Hideki Yukawa, Japan's first Nobel laureate, who laid the foundation for an active postwar generation of particle physicists in Japan.

Scientists found that E-cadherin, a protein best known as the "glue" holding cells and tissues together, also helps epithelial cells swallow nearby dead cells. Using live zebrafish and mouse embryos, researchers observed cells dramatically reshaping their lower surfaces to engulf cellular debris while keeping upper surfaces stable, allowing protective barriers to remain sealed.

Nature Medicine lists a randomized, double-blind, active-comparator-controlled phase 3 trial comparing oral small-molecule GLP-1RA safiglipron with dapagliflozin in type 2 diabetes. The feed item provides no further context, so no trial results can be reported.

In a small trial, high-dose vitamin B3 (niacin) added to standard glioblastoma treatment showed early promise, with 82% of patients remaining progression-free after six months. Researchers believe niacin may help revive immune cells suppressed by the cancer, but larger studies are still needed to confirm the benefit and safety.

A small clinical trial found that a vitamin D analog may help break down pancreatic cancer's protective defenses, potentially making tumors more vulnerable to chemotherapy and immune attack, with encouraging responses seen especially in patients whose tumors had high levels of the vitamin D receptor.

A two-year randomized clinical trial of 493 adults with overweight or obesity found that diet soft drinks sweetened with aspartame, acesulfame-K, or sucralose were essentially as effective as water for long-term weight loss and weight maintenance. Both groups also showed improvements in waist size, body composition, and several metabolic measures.

According to ScienceDaily, the essential amino acid leucine can boost cellular energy production by protecting key proteins on mitochondria from being destroyed. The discovery reveals a new connection between nutrition and metabolism that could eventually lead to new approaches for metabolic disorders and cancer.

Scientists have linked a gut bacterial compound called ImP to greater Alzheimer's risk, harmful brain protein buildup, and faster cognitive decline. The finding raises the possibility that reducing ImP in the blood could one day help slow or prevent dementia, though this remains unproven.

In a phase 2 trial of people with precancerous or low-risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow-up also found fewer deaths among participants taking vitamin C than among those receiving placebo.

High-risk MDS stem cells appear to have an unexpected "energy addiction," relying far more heavily than healthy blood-forming cells on a molecule called NAD; disrupting this energy pathway selectively weakened the cancer-driving cells, revealing a potential new target for treatment.

An Australian study found that weak sunlight can still damage skin DNA when people spend enough time outdoors. Even UV doses too low to cause visible redness triggered cellular damage that could accumulate over time and contribute to skin cancer risk.

Nature Medicine published a pragmatic cluster-randomized trial examining small-quantity lipid-based nutritional supplementation and measles vaccination coverage among children aged 6 to 23 months. No study background or results are provided in the available context, so no outcome can be reported.

A Nature Medicine item concerns the use of urine cell-free RNA for bladder cancer detection and prediction of treatment response. No further context was provided, so the methods, stage, and findings are not stated here.